Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

UW-Madison said reductions in NIH funding will "ultimately harm the livelihoods of real people across Wisconsin and the ...

Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...

Feb. 4, 2025 — Scientists provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease. Their findings, ... Scientists Identify ...

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

A new biomarker test developed at the University of Pittsburgh could help doctors doctors detect signs of Alzheimer's years sooner, according to research published Monday in Nature Medicine.

In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...

Ongoing collaboration between Eisai and Biogen indicates a strong partnership in the development and commercialization of new treatments for Alzheimer's disease. The European Commission has ...